Lexeo Therapeutics, Inc./$LXEO
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Lexeo Therapeutics, Inc.
Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.
Ticker
$LXEO
Sector
Primary listing
Industry
Biotechnology
Headquarters
Employees
75
ISIN
US52886X1072
Website
LXEO Metrics
BasicAdvanced
$233M
-
-$3.31
-
-
Price and volume
Market cap
$233M
52-week high
$5.55
52-week low
$1.45
Average daily volume
851K
Financial strength
Current ratio
3.415
Quick ratio
3.239
Long term debt to equity
7.663
Total debt to equity
10.667
Interest coverage (TTM)
-908.44%
Profitability
EBITDA (TTM)
-115.665
Management effectiveness
Return on assets (TTM)
-42.89%
Return on equity (TTM)
-80.65%
Valuation
Price to book
1.6
Price to tangible book (TTM)
1.6
Price to free cash flow (TTM)
-1.588
Free cash flow yield (TTM)
-62.96%
Free cash flow per share (TTM)
-266.96%
Growth
Earnings per share change (TTM)
-43.12%
LXEO News
AllArticlesVideos
Lexeo Therapeutics Announces $80 Million Equity Financing to Further Advance Development of Transformative Genetic Medicines for Cardiovascular Diseases
GlobeNewsWire·4 weeks ago
Lexeo Therapeutics Reports First Quarter 2025 Financial Results and Operational Highlights
GlobeNewsWire·1 month ago
Lexeo Therapeutics to Present New CMC Data at the 28th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
GlobeNewsWire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Lexeo Therapeutics, Inc. stock?
Lexeo Therapeutics, Inc. (LXEO) has a market cap of $233M as of June 21, 2025.
What is the P/E ratio for Lexeo Therapeutics, Inc. stock?
The price to earnings (P/E) ratio for Lexeo Therapeutics, Inc. (LXEO) stock is 0 as of June 21, 2025.
Does Lexeo Therapeutics, Inc. stock pay dividends?
No, Lexeo Therapeutics, Inc. (LXEO) stock does not pay dividends to its shareholders as of June 21, 2025.
When is the next Lexeo Therapeutics, Inc. dividend payment date?
Lexeo Therapeutics, Inc. (LXEO) stock does not pay dividends to its shareholders.
What is the beta indicator for Lexeo Therapeutics, Inc.?
Lexeo Therapeutics, Inc. (LXEO) does not currently have a Beta indicator.